FDA approves new multiple sclerosis treatment: Tecfidera

The U.S. Food and Drug Administration today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS).

Home | Copyright 2008-2024 FoodandDrugRecall.org